Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Enzo Biochem settles with Chugai and bioMerieux:

This article was originally published in Clinica

Executive Summary

Enzo Biochem has settled a patent dispute with Chugai Pharmaceutical of Japan, which was acquired last year by Roche, and bioMerieux's US arm in Durham, North Carolina. Roche says the dispute will have no financial effect on it, because it concerned the Gen-Probe unit that has now been spun out. Farmingdale, New York-based Enzo's law suit, which relates to its US patent No 4,900,659 covering genetic probes for detecting Neisseria gonorrhoeae, continues with Gen-Probe and another defendant, Becton Dickinson. The terms of the settlement were not disclosed.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT061541

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel